Buy One Get One free -Llimited Time Offer X
Mabtas Ra, a prescription drug, is manufactured in various forms such as Injection. It is typically used for the treatment of Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia. Secondary and off-label uses of Mabtas Ra have also been mentioned below.
The optimal dosage of Mabtas Ra is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Mabtas Ra include Weakness. Some other side effects of Mabtas Ra have been listed ahead. Usually, these side effects of Mabtas Ra go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Mabtas Ra has a Moderate effect for pregnant women and Severe effect on lactating mothers. Warnings related to Mabtas Ra's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Hyperkalemia must refrain from the use of Mabtas Ra since this can cause severe adverse effects. Some other conditions that can be affected by Mabtas Ra are listed in the contraindications section below.
Drug interactions for Mabtas Ra have been reported in the medical literature. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Mabtas Ra is considered not safe while driving, and is not addictive.
Mabtas Ra is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Mabtas Ra is used -
Moderate
Mild
Common
Is the use of Mabtas Ra safe for pregnant women?
Mabtas RA can have harmful effects in pregnant women. If you experience any discomfort after using Mabtas RA, then discontinue the use and take your doctor's advice.
Is the use of Mabtas Ra safe during breastfeeding?
Mabtas RA should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Mabtas Ra on the Kidneys?
There can be some harmful effects on your kidneys after taking Mabtas RA. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Mabtas Ra on the Liver?
There are no any side effects of Mabtas RA on the liver.
What is the effect of Mabtas Ra on the Heart?
You may experience side effects on your heart after taking Mabtas RA. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Mabtas Ra should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Mabtas Ra unless your doctor advises you to do so -
Is this Mabtas Ra habit forming or addictive?
Mabtas Ra does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Mabtas Ra can make you feel drowsy.
Is it safe?
Mabtas Ra should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Mabtas Ra for mental disorders.
Interaction between Food and Mabtas Ra
It is safe to take Mabtas Ra with food.
Interaction between Alcohol and Mabtas Ra
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Mabtas Ra.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rituxan (rituximab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1106-1109
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872